A Deeper Understanding of Maternal Alloimmunization and Hemolytic Disease of the Fetus/Newborn

Guest: Kenneth J. Moise Jr., MD <br> Host: Charles Turck, PharmD, BCPS, BCCCP <br> <p>Hemolytic disease of the fetus/newborn (HDFN) may be rare, but it is important to recognize and diagnose the disease and ensure appropriate patient management since the consequences in cases that go undiagnosed or are poorly managed can be devastating. To help us gain a better understanding of maternal alloimmunization and the risk for HDFN in pregnancy, Dr. Charles Turck speaks with Dr. Kenneth Moise, Director of the Comprehensive Fetal Care Center in Texas. </p> <p>© Janssen Pharmaceuticals, Inc. 2022 12/21 cp-<span>272563</span>v1</p>